Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GALVANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.543
EU - Europa 4.438
AS - Asia 3.830
SA - Sud America 697
AF - Africa 140
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.396
SG - Singapore 1.558
RU - Federazione Russa 1.411
IT - Italia 1.055
CN - Cina 842
BR - Brasile 558
DE - Germania 485
VN - Vietnam 411
HK - Hong Kong 348
FI - Finlandia 298
PL - Polonia 264
FR - Francia 222
GB - Regno Unito 219
JP - Giappone 146
IN - India 103
IE - Irlanda 89
SE - Svezia 79
NL - Olanda 73
CA - Canada 71
KR - Corea 68
BD - Bangladesh 62
IQ - Iraq 52
MX - Messico 50
AR - Argentina 44
RO - Romania 43
TR - Turchia 41
ES - Italia 36
UA - Ucraina 36
ZA - Sudafrica 34
AT - Austria 28
BE - Belgio 26
EC - Ecuador 23
UZ - Uzbekistan 23
VE - Venezuela 23
IR - Iran 21
MY - Malesia 21
EG - Egitto 20
MA - Marocco 18
AU - Australia 17
ID - Indonesia 17
KE - Kenya 17
CI - Costa d'Avorio 16
SA - Arabia Saudita 16
PK - Pakistan 14
CH - Svizzera 12
PH - Filippine 12
LT - Lituania 11
NP - Nepal 11
CL - Cile 10
CO - Colombia 10
TN - Tunisia 10
PY - Paraguay 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
AM - Armenia 6
AZ - Azerbaigian 6
BG - Bulgaria 6
PE - Perù 6
DZ - Algeria 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
TW - Taiwan 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
GH - Ghana 4
JM - Giamaica 4
PS - Palestinian Territory 4
CR - Costa Rica 3
EE - Estonia 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
LV - Lettonia 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MM - Myanmar 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BW - Botswana 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
Totale 17.649
Salva come PNG Salva come JPEG
Città #
Ashburn 1.143
Fairfield 975
Singapore 945
Chandler 487
Houston 451
San Jose 433
Seattle 414
Woodbridge 405
Wilmington 349
Cambridge 335
Hong Kong 330
Moscow 284
Palermo 281
Ann Arbor 261
Zgierz 217
Helsinki 186
Council Bluffs 173
Beijing 164
Rome 151
New York 144
Los Angeles 143
Ho Chi Minh City 137
The Dalles 135
Tokyo 134
Dallas 116
Lauterbourg 110
Medford 102
Munich 102
Hefei 100
Hanoi 98
Santa Clara 88
Des Moines 87
Dublin 85
Boardman 79
Altamura 77
Chicago 69
Princeton 65
Frankfurt am Main 62
Lawrence 60
São Paulo 59
Buffalo 57
Ludwigshafen am Rhein 54
San Diego 53
London 48
Nanjing 47
Milan 43
Warsaw 41
Seoul 38
Orem 37
Lappeenranta 32
Schiffdorf 32
Bremen 31
Dearborn 30
Nuremberg 29
Kitzingen 27
Montreal 27
Denver 26
Brooklyn 25
Panama City 25
Atlanta 24
Brussels 23
Johannesburg 22
Redondo Beach 21
Mexico City 20
Phoenix 20
Stockholm 20
Chennai 19
Falls Church 19
Shanghai 19
Tashkent 19
Amsterdam 18
Baghdad 18
Salt Lake City 18
Shenyang 18
Haiphong 17
Redwood City 17
Abidjan 16
Da Nang 16
Kumar 16
Cairo 15
Nanchang 15
Tianjin 15
Boston 14
Guangzhou 14
Hebei 14
Volla 14
Belo Horizonte 13
Poplar 13
Toronto 13
Curitiba 12
Erbil 12
Izmir 12
Jinan 12
Manchester 12
Nairobi 12
Rio de Janeiro 12
Berlin 11
Bexley 11
Kilburn 11
Kuala Lumpur 11
Totale 11.386
Salva come PNG Salva come JPEG
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 351
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 344
Dietary restriction: could it be considered as speed bump on tumor progression road? 323
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 322
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 319
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 318
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 306
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 301
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 300
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 283
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 282
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 272
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 266
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 265
Nintedanib in NSCLC: Evidence to date and place in therapy 254
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 251
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 250
Monoclonal antibodies in gastrointestinal cancers 245
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 242
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 242
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 227
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 222
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 211
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis 202
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 200
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 199
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 199
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 198
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 197
2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 189
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 188
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 185
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 182
Clinical efficacy and safety of ezetimibe on major cardiovascular endpoints: Systematic review and meta-analysis of randomized controlled trials 180
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 176
Anti-angiogenic drugs for second-line treatment of NSCLC patients: Just new pawns on the chessboard? 176
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 176
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 175
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 174
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 174
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 169
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups 167
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: Recommended schedule for expected activity and safety and phase II study 166
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 162
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 161
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 160
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement 158
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 156
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 156
Dose-finding study of oxaliplatin associated to capecitabinebased preoperative chemoradiotherapy in locally advanced rectal cancer 155
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 154
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 153
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 151
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer 149
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer 147
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer 146
Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer 143
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 142
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 142
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 141
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 141
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal 140
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 140
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 139
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 139
Second medical opinion in oncological setting 139
Ramucirumab and its use in gastric cancer treatment 138
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 137
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 137
Molecular tumor board 136
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 135
Accuracy evaluation of orthodontic movements with aligners: a prospective observational study. 132
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 129
Current clinically validated applications of liquid biopsy 128
The treatment of medication-related osteonecrosis of the jaw (Mronj): A systematic review with a pooled analysis of only surgery versus combined protocols 128
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 128
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 126
The use of same in chemotherapy-induced liver injury 125
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials 125
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 123
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 121
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 118
Scientific Communication and oncology – "The bridge between knowledge and patients" 118
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 116
Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives 115
Liquid biopsy in colorectal carcinoma: the search for potential prognostic and predictive biomarkers 114
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis 114
Indications for locoregional tumor therapies: CRC liver metastases 113
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies 111
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 107
Liquid biopsy and immunotherapy: is all that glitter gold? 107
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 106
Early detection screening: myth or reality? 105
Anti-vibration Knob for the Motorcycle, Customizable on the Basis of the Driver’s Ergonomics 105
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 104
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 104
Potential Applications of PRP-Enhanced Polybutylene Succinate Graft as Vascular Access for Chemotherapy in Oncological Patients: A Systematic Review 101
Editorial: The Effect of the COVID-19 Pandemic on Cancer Patients and Healthcare 100
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 96
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study 94
Totale 17.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/20221.163 118 208 71 39 62 60 59 65 99 139 89 154
2022/20231.404 145 274 25 180 119 216 84 123 113 20 77 28
2023/2024859 28 96 74 71 59 130 108 80 30 31 14 138
2024/20252.751 73 181 173 186 122 203 338 239 151 317 340 428
2025/20268.056 682 302 574 780 930 1.186 1.174 895 620 499 321 93
Totale 18.377